Literature DB >> 8810873

Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation.

E Kostenis1, K Mohr.   

Abstract

Allosteric modulation of a receptor may be proved experimentally by demonstrating an altered radioligand dissociation in the presence of the allosteric modulator. Two-point kinetic experiments provide a screening-type approach to determine the delay of radioligand dissociation caused by allosteric modulation. In this article, Evi Kostenis and Klaus Mohr describe a pitfall in the data analysis that may lead to a suboptimum determination of the allosteric potency in the case of monophasic dissociations, and suggest how this problem may be resolved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810873     DOI: 10.1016/0165-6147(96)10034-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  14 in total

Review 1.  Emerging paradigms in GPCR allostery: implications for drug discovery.

Authors:  Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

Review 2.  Rational design of dualsteric GPCR ligands: quests and promise.

Authors:  Klaus Mohr; Christian Tränkle; Evi Kostenis; Elisabetta Barocelli; Marco De Amici; Ulrike Holzgrabe
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

3.  Novel allosteric effects of amiodarone at the muscarinic M5 receptor.

Authors:  Edward Stahl; John Ellis
Journal:  J Pharmacol Exp Ther       Date:  2010-03-26       Impact factor: 4.030

4.  Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor.

Authors:  Dong Guo; Suzanne N Venhorst; Arnault Massink; Jacobus P D van Veldhoven; Georges Vauquelin; Adriaan P IJzerman; Laura H Heitman
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.

Authors:  Rabindra V Shivnaraine; Xi-Ping Huang; Margaret Seidenberg; John Ellis; James W Wells
Journal:  Biochemistry       Date:  2012-05-24       Impact factor: 3.162

6.  Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

Authors:  Matthew D Hill; Haiquan Fang; Jeffrey M Brown; Thaddeus Molski; Amy Easton; Xiaojun Han; Regina Miller; Melissa Hill-Drzewi; Lizbeth Gallagher; Michele Matchett; Michael Gulianello; Anand Balakrishnan; Robert L Bertekap; Kenneth S Santone; Valerie J Whiterock; Xiaoliang Zhuo; Joanne J Bronson; John E Macor; Andrew P Degnan
Journal:  ACS Med Chem Lett       Date:  2016-10-03       Impact factor: 4.345

7.  A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway.

Authors:  Eugénie Goupil; Danaë Tassy; Carine Bourguet; Christiane Quiniou; Veronica Wisehart; Darlaine Pétrin; Christian Le Gouill; Dominic Devost; Hans H Zingg; Michel Bouvier; Horacio Uri Saragovi; Sylvain Chemtob; William D Lubell; Audrey Claing; Terence E Hébert; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

8.  In vivo investigations on the cholinesterase-inhibiting effects of tricyclic quinazolinimines: scopolamine-induced cognitive impairments in rats are attenuated at low dosage and reinforced at higher dosage.

Authors:  D Appenroth; M Decker; C Tränkle; K Mohr; J Lehmann; C Fleck
Journal:  Pflugers Arch       Date:  2007-08-24       Impact factor: 3.657

9.  Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2.

Authors:  Regina Messerer; Clelia Dallanoce; Carlo Matera; Sarah Wehle; Lisa Flammini; Brian Chirinda; Andreas Bock; Matthias Irmen; Christian Tränkle; Elisabetta Barocelli; Michael Decker; Christoph Sotriffer; Marco De Amici; Ulrike Holzgrabe
Journal:  Medchemcomm       Date:  2017-04-27       Impact factor: 3.597

Review 10.  Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.

Authors:  Stephen J Hill; Lauren T May; Barrie Kellam; Jeanette Woolard
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.